•    2010
•    2009
•    2008
•    2007
•    2006-1992

2010

• Activated macrophages as a novel determinant of tumor cell radioresponse: the role of nitric oxide-mediated inhibition of cellular respiration and oxygen sparing. Jiang H, De Ridder M, Verovski VN, Sonveaux P, Jordan BF, Law K, Monsaert C, Van den Berge DL, Verellen D, Feron O, Gallez B, Storme GA. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1520-7.

• Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer. Vinh-Hung V, Joseph SA, Coutty N, Ly BH, Vlastos G, Nguyen NP. Oncologist. 2010; 15(10):1050-62.

• Altered glucose metabolism during chemoradiation for head and neck cancer. Nguyen NP, Vos P, Vinh-Hung V, Borok TL, Dutta S, Karlsson U, Lee H, Martinez T, Jo BH, Nguyen LM, Nguyen N, Sallah S. Anticancer Res. 2009 Nov;29(11):4683-7.

• An in-house developed resettable MOSFET dosimeter for radiotherapy. Verellen D, Van Vaerenbergh S, Tournel K, Heuninckx K, Joris L, Duchateau M, Linthout N, Gevaert T, Reynders T, Van de Vondel I, Coppens L, Depuydt T, De Ridder M, Storme G. Phys Med Biol. 2010 Feb 21;55(4):N97-109.

• Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients? Farrag A, Ceulemans G, Voordeckers M, Everaert H, Storme G. Nucl Med Commun. 2010 Jun; 31(6):495-501.

• Daily Megavoltage Computed Tomography in Lung Cancer Radiotherapy: Correlation Between Volumetric Changes and Local Outcome. Bral S, De Ridder M, Duchateau M, Gevaert T, Engels B, Schallier D, Storme G. Int J Radiat Oncol Biol Phys. 2010 Jul 15. [Epub ahead of print]. 

• The effect of tomotherapy imaging beam output instabilities on dose calculation. Duchateau M, Tournel K, Verellen D, Van de Vondel I, Reynders T, Linthout N, Gevaert T, de Coninck P, Depuydt T, Storme G. Phys Med Biol. 2010 Jun;55(11):N329-36.

• Effectiveness of Image-Guided Radiotherapy for Locally Advanced Rectal Cancer. Nguyen NP, Ceizyk M, Almeida F, Chi A, Betz M, Modarresifar H, Sroka T, Cohen D, Jang S, Abraham D, Stevie M, Smith-Raymond L, Krafft S, Vinh-Hung V. Ann Surg Oncol. 2010 Sep 17. [Epub ahead of print]

• Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors. Bouchardy C, Rapiti E, Usel M, Majno SB, Vlastos G, Benhamou S, Miralbell R, Neyroud-Caspar I, Verkooijen HM, Vinh-Hung V. Ann Oncol. 2010 Mar; 21(3):459-65.

• External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Bolla M, Van Tienhoven G, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Billiet I, Torecilla JL, Pfeffer R, Cutajar CL, Van der Kwast T, Collette L. Lancet Oncol. 2010 Nov; 11(11):1066-73.

• Gating and tracking, 4D in thoracic tumours. Verellen D, Depuydt T, Gevaert T, Linthout N, Tournel K, Duchateau M, Reynders T, Storme G, De Ridder M. Cancer Radiother. 2010 Oct; 14(6-7):446-54. Review.

• Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson U, Vinh-Hung V. QJM. 2010 Apr; 103(4):229-36. Review.

• Image-guided marker placement in liver tumors for stereotactic radiotherapy: technique and safety. Vandenbroucke F, Vinh-Hung V, Craggs B, Buls N, de Mey J. J Comput Assist Tomogr. 2010 May-Jun; 34(3):367-71.

• Importance of age as a prognostic factor for tonsillar carcinoma. Nguyen NP, Ly BH, Betz M, Vinh-Hung V. Ann Surg Oncol. 2010 Oct; 17(10):2570-7.

• Innovations in locoregional treatments of breast cancer. Vlastos G, Monnier S, Vinh-Hung V. Rev Med Suisse. 2010 Oct 27; 6(268):2016, 2018-23. French.

• Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit? Ly BH, Nguyen NP, Vinh-Hung V, Rapiti E, Vlastos G. Breast Cancer Res Treat. 2010 Feb; 119(3):537-45. Review.

• Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Bouchardy C, Benhamou S, Schaffar R, Verkooijen HM, Fioretta G, Schubert H, Vinh-Hung V, Soria JC, Vlastos G, Rapiti E. Cancer. 2011 Jan 24. doi: 10.1002/cncr.25638.

• Management of skin reactions during radiotherapy in Flanders (Belgium): a study of nursing practice before and after the introduction of a skin care protocol. D'haese S, Van Roy M, Bate T, Bijdekerke P, Vinh-Hung V. Eur J Oncol Nurs. 2010 Dec;14(5):367-72.

• Molecular biology of breast cancer stem cells: potential clinical applications. Nguyen NP, Almeida FS, Chi A, Nguyen LM, Cohen D, Karlsson U, Vinh-Hung V. Cancer Treat Rev. 2010 Oct;36(6):485-91.Review.

• Pattern of failure after helical tomotherapy in head and neck cancer. Farrag A, Voordeckers M, Tournel K, De Coninck P, Storme G. Strahlenther Onkol. 2010 Sep; 186(9):511-6.

• Phase II study of helical tomotherapy for oligometastatic colorectal cancer.Engels B, Everaert H, Gevaert T, Duchateau M, Neyns B, Sermeus A, Tournel K, Verellen D, Storme G, De Ridder M. Ann Oncol. 2011 Feb; 22(2):362-8.

• Prediction of Response to Neoadjuvant Radiotherapy in Patients with Locally Advanced Rectal Cancer by Means of Sequential 18FDG-PET. Everaert H, Hoorens A, Vanhove C, Sermeus A, Ceulemans G, Engels B, Vermeersch M, Verellen D, Urbain D, Storme G, De Ridder M. Int J Radiat Oncol Biol Phys. 2010 Jun 2. [Epub ahead of print]

• Prospective, Risk-Adapted Strategy of Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: Results of a Phase II Trial. Bral S, Gevaert T, Linthout N, Versmessen H, Collen C, Engels B, Verdries D, Everaert H, Christian N, De Ridder M, Storme G. Int J Radiat Oncol Biol Phys. 2010 Aug 12. [Epub ahead of print].

• Risk of second breast cancer according to estrogen receptor status and family history. Bouchardy C, Benhamou S, Fioretta G, Verkooijen HM, Chappuis PO, Neyroud-Caspar I, Castiglione M, Vinh-Hung V, Vlastos G, Rapiti E. Breast Cancer Res Treat. 2010 Sep 29. [Epub ahead of print]

• Stereotactic body radiation therapy: the report of AAPM Task Group 101. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, Purdie T, Sadagopan R, Schell MC, Salter B, Schlesinger DJ, Shiu AS, Solberg T, Song DY, Stieber V, Timmerman R, Tomé WA, Verellen D, Wang L, Yin FF. Med Phys. 2010 Aug;37(8):4078-101.

• Survival benefit with radiation therapy in node-positive breast carcinoma patients. Voordeckers M, Vinh-Hung V, Lamote J, Bretz A, Storme G. Strahlenther Onkol. 2009 Oct; 185(10):656-62.

• The effect of tomotherapy imaging beam output instabilities on dose calculation. Duchateau M, Tournel K, Verellen D, Van de Vondel I, Reynders T, Linthout N, Gevaert T, de Coninck P, Depuydt T, Storme G. Phys Med Biol. 2010 Jun 7;55(11):N329-36.

• The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. Korreman S, Rasch C, McNair H, Verellen D, Oelfke U, Maingon P, Mijnheer B, Khoo V. Radiother Oncol. 2010 Feb; 94(2):129-44. Review.

• The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M. Maturitas. 2009 Oct 20; 64(2):80-5. Review.

• Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy. Bral S, Duchateau M, Versmessen H, Engels B, Tournel K, Vinh-Hung V, De Ridder M, Schallier D, Storme G. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1352-9.

• Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy. Bral S, Duchateau M, Versmessen H, Engels B, Tournel K, Vinh-Hung V, De Ridder M, Schallier D, Storme G. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1352-9.

• Volumetric imaging by megavoltage computed tomography for assessment of internal organ motion during radiotherapy for cervical cancer. Collen C, Engels B, Duchateau M, Tournel K, De Ridder M, Bral S, Verellen D, Storme G. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1590-5.

• Vorsprung durch Technik: evolution, implementation, QA and safety of new technology in radiotherapy. Thwaites DI, Verellen D. Radiother Oncol. 2010 Feb; 94(2):125-8.

2009

• Voordeckers M, Vinh-Hung V, Lamote J, Bretz A, Storme G. Survival benefit with radiation therapy in node-positive breast carcinoma patients. Strahlenther Onkol 2009; 185: 656-62.

• Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. Maturitas. 2009 Oct 20;64(2):80-5. 

• Vinh-Hung V, Truong PT, Janni W, Nguyen NP, Vlastos G, Cserni G, Royce ME, Woodward WA, Promish D, Tai P, Soete G, Balmer-Majno S, Cutuli B, Storme G, Bouchardy C. The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer. Strahlenther Onkol. 2009 Mar;185(3):161-8; discussion 169.

• Bral S, Duchateau M, De Ridder M, Everaert H, Tournel K, Schallier D, Verellen D, Storme G. Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC. Radiother Oncol 2009; 91(3): 438-442.

• C. Chaskis, B. Neyns, A. Michotte, M. De Ridder & H. Everaert . Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations . Surgical Neurology, 72(4):423-8, 2009 

• S. Bral, M. Duchateau, H. Versmessen, D. Verdries, B. Engels, M. De Ridder, K. Tournel, C. Collen, H. Everaert, D. Schallier, J. De Greve and Storme G. Toxicity report of a dose escalation study in inoperable locally advanced non-small cell lung cancer with helical tomotherapy and concurrent chemotherapy. Cancer 2009, in press. 

• S. Bral, M. Duchateau, H. Versmessen, B. Engels, K. Tournel, V. Vinh-Hung, M. De Ridder, D. Schallier and G. Storme. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable stage III non-small cell lung cancer using helical tomotherapy. International Journal of Radiation Oncology • Biology • Physics 2009, in press. 

• Bolla M, de Reijke TM, Van Tienhoven G, Van den Bergh AC, Oddens J, Poortmans PM, Gez E, Kil P, Akdas A, Soete G, Kariakine O, van der Steen-Banasik EM, Musat E, Piérart M, Mauer ME, Collette L; EORTC Radiation Oncology Group and Genito-Urinary Tract Cancer Group. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med. 2009 Jun 11;360(24):2516-27. 

• Arcangeli S, Strigari L, Soete G, De Meerleer G, Gomellini S, Fonteyne V, Storme G, Arcangeli G. Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):39-45.

• De Ridder M, Engels B, Tournel K, Verellen D, Storme G. Präoperative helikale tomotherapie beim rektumkarzinom. Klinische Onkologie 2009; 3: 69-80

• Duchateau M, Tournel K, Verellen D, Van de Vondel I, Reynders T, De Coninck P, Linthout N, Gevaert T, Storme G. The effect of tomotherapy imaging beam output variation on dose calculation. Phys Med Biol 2009; (Submitted)

• Engels B, Soete G, Verellen D, Storme G. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distened rectum on the planning CT in spite of image guidance by implanted markers. Int J Radiat Oncol Biol Phys 2009; 74(2):388-91

• Engels B, De Ridder M, Tournel K, Sermeus A, De Coninck P, Verellen D, Storme G, Preoperative helical tomotherapy and megavolt computed tomography for rectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 2009; 74(5): 1476-80

• Engels B, Soete G, Tournel K, Bral S, De Coninck P, Verellen D, Storme G. Helical tomotherapy with simultaneous integrated boost for high-risk and lymph node-positive prostate cancer: early report on acute and late toxicity. Technol Cancer Res Treat 2009; 8(5): 353-60

• Jiang H, De Ridder M, Verovski V, Sonveaux P, Jordan BB, Law K, Monsaert C, Van den Berge D, Verellen D, Feron O, Gallez B, Storme G. Activated macrophages as a novel determinant of tumor cell radioresponse: the role of nitric oxide-mediated inhibition of cellular respiration and oxygen sparing. Int J Radiat Oncol Biol Phys 2009 (Submitted). 

• Linthout N, Bral S, Van de Vondel I, Verellen D, Tournel K, Gevaert T, Duchateau M, Reynders T, Storme G. Treatment delivery time optimization of respiratory gated radiation therapy by application of audio-visual feedback. Radiother Oncol 2009; 91(3): 330-335 

• Reynders T, Tournel K, De Coninck P, Heymann S, Vinh-Hung V, Van Parijs H, Duchateau M, Linthout N, Gevaert T, Verellen D, Storme G. Dosimetric assessment of static and helical tomotherapy in the liniaal implementation of breast cancer treatments. Radiother Oncol 2009; (In Press) 

• Verellen D, De Ridder M, Linthout N, Tournel K, Duchateau M, Gevaert T, Reynders T, Depuydt T, Storme G Impact of the interplay between advances in imaging and radiotherapy on clinical care. Future Medicine 2009 (In Press). 

• Verellen D, Van Vaerenbergh S, Heuninckx K, Tournel K, Joris L, Duchateau M, Linthout N, Gevaert T, Reynders T, Van de Vondel I, Coppens L, Depuydt T, Storme G. An in-house developed resettable MOSFET dosimeter for radiotherapie. Phys Med Biol 2009 (submitted).

• Bouchardy C, Rapiti E, Usel M, Majno SB, Vlastos G, Benhamou S, Miralbell R, Neyroud-Caspar I, Verkooijen HM, Vinh-Hung V. Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors. Ann Oncol. 2009 Aug 24. 

• Verkooijen HM, Rapiti E, Fioretta G, Vinh-Hung V, Keller J, Benhamou S, Vlastos G, Chappuis PO, Bouchardy C. Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups. Cancer Causes Control. 2009 Aug 22. 

• Nguyen NP, Borok TL, Welsh J, Vinh-Hung V. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax. 2009 Feb;64(2):174-8. Review. 

• Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, Deglise C, Usel M, Lutz JM, Bouchardy C. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009 Mar 1;27(7):1062-8. 

• Merglen A, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Vinh-Hung V, Vlastos G, Chappuis PO, Castiglione M, Rapiti E, Bouchardy C. Hormonal therapy for oestrogen receptor-negative breast cancer is associated with higher disease-specific mortality. Ann Oncol. 2009 May;20(5):857-61.

2008

• Bijdekerke P, Verellen D, Tournel K, Vinh-Hung V, Somers F, Storme G. Tomotherapy: Implications on daily workload and scheduling patients. Radiother Oncol 2008; 86(2): 224-230.

• B. Neyns, M. Aerts, Y. Van Nieuwenhove, C. Fontaine, L. De Coster, D. Schallier, J. Vanderauwera, F. De Munck, F. Vandenbroucke, H. Everaert, V. Meert, J. De Mey, M. De Ridder, G. Delvaux & J. De Grève. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases. Anticancer Research 2008, Jul-Aug, 28(4C):2459-67 

• M. De Ridder, D. Verellen, V. Verovski & G. Storme. Hypoxic tumor cell radiosensitization through nitric oxide. Nitric Oxide, 19(2): 164-169, 2008.

• De Ridder M, Tournel K, Van Nieuwenhove Y, Engels B, Hoorens A, Everaert H, Op de Beeck B, Vinh-Hung V, De Greve J, Verellen D, Storme G, Phase II Study of Helical TomoTherapy for the Preoperative Radiotherapy of Rectal Cancer. Int J Radiat Oncol Biol Phys 2008; 70(3): 728-734

• De Ridder M, Jiang H, Van Esch G, Law K, Monsaert C, Van den Berge D, Verellen D, Verovski V, Storme G, IFN-+ CD8+ T Lymphocytes: Possible link between immune and radiation responses in tumor-relevant hypoxia. Int J Radiat Oncol Biol Phys 2008; 71(3): 647-651.

• De Ridder M, Verellen D, Linthout N, Tournel K, Bral S, Storme G. Image-guided Radiotherapy. Belgian J Med Oncol 2008; 2(5): 255-263.

• De Ridder M, Verellen D, Verovski V, Storme G. Hypoxic tumor cell radiosensitization through Nitric Oxide. Nitric Oxide 2008; 19(2):164-169

• Dujardin M, Sourbron S, Chaskis C, Verellen D, Stadnik T, de Mey J, Luypaert R, Quantification of cerebral tumor blood flow and permeability with a deconvolution analysis of T1-weighted bolus tracking data. Am J Neuroradiol 2008; (Submitted).

• Ringborg U, de Valeriola D, van Harten W, Bosch AL, Lombardo C, Nilsson K, Philip T, Pierotti MA, Riegman P, Saghatchian M, Storme G, Tursz T, Verellen D. Improvement of European translational cancer research. Collaboration between comprehensive cancer centers. Tumori 2008; 94(2): 143-146

• Soete G, Verellen D, Storme G. Image-guided radiotherapy for prostate cancer. Bull Cancer 2008; 95(3): 374-80

• Tournel K, De Ridder M, Engels B, Bijdekerke P, Fierens Y, Duchateau M, Linthout N, Reynders T, Verellen D, Storme G, Assessment of intra-fraction movement and internal motion in radiotherapy of rectum cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys 2008; 71(3): 934-939

• Voordeckers M, Everaert H, Tournel K, Verellen D, Van Esch G, Vanhove C, Storme G, Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer. Strahlenther Onkol 2008; 8: 400-404

• Verellen D, De Ridder M, and Storme G. A (short) history of image-guided radiation therapy. Radiother Oncol 2008; 86: 4-13.

• Verellen D, De Ridder M, Linthout N, Tournel K, Soete G, Storme G. Erratum: Innovations and advances in radiation technology. Nature Reviews Cancer 2008; 8: 71.

• Verellen D. Veroorzaakt radiotherapie haaruitval? Kanker: weg met de vooroordelen (publ. van Stichting Tegen Kanker) 2008: 78-79.

• Verellen D, De Ridder M, Tournel K, Duchateau M, Reynders T, Gevaert T, Linthout N, Storme G. An overview of volumetric imaging technologies and their quality assurance for IGRT. Acta Oncol 2008; 47(7): 1271-1278.

• Verellen D, Ridder MD, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer. 2007; Dec: 7(12): 949-60. Review. Erratum in: Nat Rev
  Cancer. 2008; Jan: 8 (1):71.

2007

• Baumert BG, Spahr MO, Hochstetter AV, Beauvois S, Landmann C, Fridrich K, Villa S, Kirschner MJ, Storme G, Thum P, Streuli HK, Lombriser N, Maurer R, Ries G, Bleher EA, Willi A, Allemann J, Buehler U, Blessing H, Luetolf UM, Davis JB, Seifert B, Infanger M. The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol 2007; Mar 7: 2:12.
   
• Bori R, Vinh-Hung V, Vajda K, Svebis M, Cserni G. The impact of the largest metastasis size on nodal tumor burden in colorectal carcinomas: implications for the sentinel lymph node theory in cancers of the large intestine. J Surg Oncol 2007; 95: 629-34.
    
• Linthout N, Verellen D, Tournel K, Reynders T, Duchateau M, Storme G. Assessment of secondary patient motion induced by automated couch movement during on-line 6 dimensional repositioning in prostate cancer treatment. Radiother Oncol 2007; May 83(2):168-74.
   
• Soete G, De Cock M, Verellen D, Michielsen D, Keuppens F, Storme G. X-ray-assisted positioning of patients treated by conformal arc radiotherapy for prostate cancer: comparison of setup accuracy using implanted markers versus bony structures. Int J Radiat Oncol Biol Phys 2007; Mar 1; 67(3): 823-7.
   
• Verellen D. Point – Counter Point: “Future developments in external beam radiotherapy will be unlikely to significantly improve treatment outcomes over those currently achieved with 3D-conformal and IMRT treatments”, against the proposition. Med Phys 2007; 34(8): 1-4. 
   
• Tournel K, Verellen D, Duchateau M, Fierens Y, Linthout N, Reynders T, Voordeckers M, Storme G. An assessment of the use of skin flashes in helical tomotherapy using phantom and in-vivo dosimetry. Radiother Oncol. 2007; Jul: 84(1): 34-9. Epub 2007 Jun 27.
   
• Heymann S, Vinh-Hung V, Reynders T, Tournel K, De Coninck P, Verellen D, Storme G. In regards to Caudell et Al. Int j radiat oncol biol phys. 2007: 65: 640-645.
  Int J Radiat Oncol Biol Phys. 2007; Dec 1: 69(5): 1650; author reply 1650-1.
   
• Verellen D, Soete G, Erbel S, Labsik U. Comment on "Image-guided patient positioning: if one cannot correct for rotational offsets in external-beam radiotherapy setup, how should rotational offsets be managed?". Med Phys. 2007: 34: 1880-1883. Med Phys. 2007; Oct: 34 (10): 4064-5; author reply 4066-7.
   
• Bral S, Van Parijs H, Soete G, Linthout N, Van Moorter L, Verellen D, Storme G. A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer. Radiother Oncol. 2007; Sep: 84(3): 252-6.
   
• Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G, Vlastos A. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer. 2007; 23(7): 164 (IF = 2,4).
   
• Verellen D, De Ridder M, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nature Reviews Cancer. 7(12): 949-60. (IF = 31,6).
   
• Verellen D, Image-guided Radiotherapy. European Oncological Disease. 2007; 1: 90-94.
   
• Verellen D, Schulz RJ, Orton CG, Point/Counterpoint. Future developments in external beam radiotherapy will be unlikely to significantly improve treatment outcomes over those currently achieved with 3D-conformal and IMRT treatments (against the proposition). Med Phys. 2007; 34(8): 3123-3126.
   
• Baechler S, Bochud F, Verellen D, Moeckli R. Shielding requirements in helical tomotherapy. Phys Med Biol. 2007; 52(16): 5057-5067.
   
• Tournel K, De Ridder M, Engels B, Bijdekerke P, Fierens Y, Duchateau M, Linthout N, Reynders T, Verellen D, Storme G. Assessment of intra-fraction movement in the treatment of rectum cancer patients on tomotherapy using MV-CT. Radiother Oncol (Submitted; 2007).

2006-1992

Les publications avant 2006:

Publicaties radiotherapie-oncologie: 1992-2006